Home » Topics » BioWorld Science

BioWorld Science
RSS

Reversible, selective, potent BTK inhibitors identified by Tethering-fragment-based screening

Aug. 28, 2019

Forward genetics identifies new immune player

Aug. 28, 2019

CPRIT grant supports Emtora's development of eRapa for familial adenomatous polyposis

Aug. 27, 2019

ADC Therapeutics and Freenome enter biomarker collaboration for ADCT-402 program

Aug. 27, 2019

Phase IIb CONDUCT study of cobitolimod in ulcerative colitis meets primary endpoint

Aug. 27, 2019

New global phase IIa study evaluates tezepelumab for moderate to very severe COPD

Aug. 27, 2019

Basilea completes enrollment in phase I study of oral BAL-101553 in brain cancer

Aug. 27, 2019

DNA's sweet tooth linked to increased cancer risk with diabetes

Aug. 27, 2019

Ivy, Salarius Pharmaceuticals enter collaboration to develop new cancer treatment for glioblastoma

Aug. 27, 2019

Ubiquitin carboxyl-terminal hydrolase 19 inhibitors discovered at Almac Discovery

Aug. 27, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...